Trial Profile
Randomized Study on the Efficacy and Safety of Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2009
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms PEG/RBV POST-TOH
- 03 Jun 2009 New trial record.